Placebo controlled trial of clarithromycin in active Crohn's disease

K Leiper, K Martin, A Ellis, A J M Watson, A I Morris, J M Rhodes

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)


Crohn's disease is characterized by defective innate immune responses to intestinal bacteria. Clarithromycin is a broad-spectrum antibiotic that has good penetration into macrophages.
Original languageEnglish
Pages (from-to)1233-1239
Number of pages7
JournalAlimentary Pharmacology & Therapeutics
Issue number12
Publication statusPublished - Jun 2008


  • Adult
  • Anti-Bacterial Agents
  • Clarithromycin
  • Crohn Disease
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Placebos
  • Treatment Outcome

Cite this